SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies gets marketing authorisations from Ukraine for three cancer drugs

18 Mar 2024 Evaluate

Venus Remedies has expanded the reach of its oncology drugs in the Asia Commonwealth of Independent States (CIS) region with marketing authorisations from Ukraine for three cancer drugs -- paclitaxel, oxaliplatin and irinotecan. Its total volume of exports to Ukraine stands at $2.20 million. By strengthening its product portfolio in Ukraine, the company aims to increase this figure by 20 per cent in the next one year. The company is awaiting approval from Ukraine on another 10 applications for marketing authorisations.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

1027.80 8.10 (0.79%)
21-Apr-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.50
Dr. Reddys Lab 1221.70
Cipla 1231.85
Zydus Lifesciences 929.50
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×